# Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

> **NCT04771143** · PHASE1 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** AFQ056
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04771143
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07-21
- **Primary completion:** 2022-01-03
- **Final completion:** 2022-01-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study terminated/withdrawn before FPFV (no patients enrolled)
- **Last updated:** 2021-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04771143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04771143, "Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04771143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*